ParkwayHealth Shanghai International Hospital, a joint venture between Parkway Pantai Ltd and Shanghai Hongxin Medical Investment Holding Co Ltd. Parkway Pamtai is part of IHH Healthcare.
KUALA LUMPUR: Parkway Pantai Ltd and Shanghai Hongxin Medical Investment Holding Co Ltd will be developing a 450-bed multi-specialty tertiary hospital in Shanghai New Hongqiao International Medical Centre, China.
In a statement, the healthcare service provider said the hospital, ParkwayHealth Shanghai International Hospital, is a 70:30 joint-venture (JV) between Parkway Pantai and Shanghai Hongxin with a registered capital of 455 million yuan (RM278.8mil).
“Today, our JV company has entered into a land contract with the Shanghai Minhang District Planning and Land Authority for the development of the hospital,” it said.
Parkway Pantai, a member of the IHH Healthcare group, said ParkwayHealth Shanghai would be the only foreign JV general hospital in Shanghai New Hongqiao International Medical Centre. It will be built on a 35,754 sq m site, acquired on a leasehold basis for 50 years.
“Slated for opening in 2020, ParkwayHealth Shanghai will offer a comprehensive range of specialties and healthcare services, with a focus on cardiology, cardiac surgery, gastroenterology, urology, minimally invasive surgery, general surgery and internal medicine,” it said.
Parkway Pantai group chief executive officer and managing director Dr Tan See Leng said the hospital would leverage on the group’s existing network of medical centres to provide integrated healthcare services for residents in the Yangtze River Delta and beyond. - Bernama
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
